Reduction Potential Predictions for Thirty-Seven 1,4-di-N-Oxide Quinoxaline-2-Carboxamide Derivatives with Anti-Tuberculosis Activity

被引:3
|
作者
Pooladian, Faranak [1 ]
Crawford, Philip W. [1 ]
Kessler, Jonathan M. [1 ]
Casey, Garrett R. [1 ]
Ragain, Christina M. [1 ]
机构
[1] Southeast Missouri State Univ, Dept Chem & Phys, Cape Girardeau, MO 63701 USA
来源
COMPOUNDS | 2023年 / 3卷 / 01期
基金
美国国家科学基金会;
关键词
quinoxaline-di-N-oxide derivatives; voltammetry; anti-tuberculosis; reduction potential; computational prediction; DFT: B3LYP/lanl2dz; lanl2dz; modified Hammett equation; QUINOXALINE;
D O I
10.3390/compounds3010007
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The ability for density functional theory with the B3LYP functional with the lanl2dz basis set to predict the 1st (Wave 1) and 2nd (Wave 2) reductions of the diazine ring in a series of thirty-seven (37) 1,4-di-N-oxide quinoxaline-2-carboxamide derivatives in dimethylformamide was examined. The B3LYP/lanl2dz method had a strong correlation and low correlation to the experimental potentials for Wave 1 and Wave 2, respectively. There are nine identifiable analogs based on similarities of structure. The predicted reduction potentials for the derivatives of each analog generally fit the modified Hammett equation. The B3LYP/lanl2dz method is shown to be useful in accurately predicting the Wave 1 potentials for quinoxaline-di-N-oxide derivatives. For derivatives with assessable anti-tuberculosis activity, the predicted Wave 1 potentials have a similar correlation with the bioactivity when compared to the experimental wave 1 potentials.
引用
收藏
页码:83 / 95
页数:13
相关论文
共 50 条
  • [21] Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives
    Carlos Villalobos-Rocha, Juan
    Sanchez-Torres, Luvia
    Nogueda-Torres, Benjamin
    Segura-Cabrera, Aldo
    Garcia-Perez, Carlos A.
    Bocanegra-Garcia, Virgilio
    Palos, Isidro
    Monge, Antonio
    Rivera, Gildardo
    PARASITOLOGY RESEARCH, 2014, 113 (06) : 2027 - 2035
  • [22] Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives
    Juan Carlos Villalobos-Rocha
    Luvia Sánchez-Torres
    Benjamín Nogueda-Torres
    Aldo Segura-Cabrera
    Carlos A. García-Pérez
    Virgilio Bocanegra-García
    Isidro Palos
    Antonio Monge
    Gildardo Rivera
    Parasitology Research, 2014, 113 : 2027 - 2035
  • [23] Improved Computational Prediction of the Electrochemical Reduction Potential of Twenty 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives
    Bhattarai, Shambhu
    Mareta, Pradeep
    Crawford, Philip W.
    Kessler, Jonathan M.
    Ragain, Christina M.
    COMPUTATION, 2023, 11 (01)
  • [24] Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide
    Ortega, MA
    Sainz, Y
    Montoya, ME
    Jaso, A
    Zarranz, B
    Aldana, I
    Monge, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2002, 52 (02): : 113 - 119
  • [25] New Amide Derivatives of Quinoxaline 1,4-di-N-Oxide with Leishmanicidal and Antiplasmodial Activities
    Barea, Carlos
    Pabon, Adriana
    Perez-Silanes, Silvia
    Galiano, Silvia
    Gonzalez, German
    Monge, Antonio
    Deharo, Eric
    Aldana, Ignacio
    MOLECULES, 2013, 18 (04) : 4718 - 4727
  • [26] Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives
    Estevez, Yannick
    Quiliano, Miguel
    Burguete, Asuncion
    Cabanillas, Billy
    Zimic, Mirko
    Malaga, Edith
    Verastegui, Manuela
    Perez-Silanes, Silvia
    Aldana, Ignacio
    Monge, Antonio
    Castillo, Denis
    Deharo, Eric
    EXPERIMENTAL PARASITOLOGY, 2011, 127 (04) : 745 - 751
  • [27] New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity
    Quiliano, Miguel
    Pabon, Adriana
    Ramirez-Calderon, Gustavo
    Barea, Carlos
    Deharo, Eric
    Galiano, Silvia
    Aldana, Ignacio
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (08) : 1820 - 1825
  • [28] New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities
    Barea, Carlos
    Pabon, Adriana
    Castillo, Denis
    Zimic, Mirko
    Quiliano, Miguel
    Galiano, Silvia
    Perez-Silanes, Silvia
    Monge, Antonio
    Deharo, Eric
    Aldana, Ignacio
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (15) : 4498 - 4502
  • [29] In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide
    Villar, Raquel
    Vicente, Esther
    Solano, Beatriz
    Perez-Silanes, Silvia
    Aldana, Ignacio
    Maddry, Joseph A.
    Lenaerts, Anne J.
    Franzblau, Scott G.
    Cho, Sang-Hyun
    Monge, Antonio
    Goldman, Robert C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (03) : 547 - 554
  • [30] PRIMAQUINE-1,4-DI-N-OXIDE QUINOXALINE HYBRIDS: POTENTIAL TISSUE SCHIZONTOCIDE ACTIVITY IN MALARIA
    Bonilla Ramirez, Leonardo
    Ramirez, Gustavo
    Franetich, Jean Francois
    Bordessoulles, Mallaury
    Tefit, Maurel
    Quiliano, Miguel
    Corcuera, Luis
    Aldana, Ignacio
    Mazier, Dominique
    Galiano, Silvia
    Pabon, Adriana
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 494 - 494